This Article Order Full text via Infotrieve Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ausprunk, D. H. Articles by Folkman, J. Search for Related Content PubMed PubMed Citation Articles by Ausprunk, D. H. Articles by Folkman, J.

American Journal of Pathology, Vol 79, 597-628, Copyright © 1975 by American Society for Investigative Pathology

REGULAR ARTICLES

Vascularization of normal and neoplastic tissues grafted to the chick chorioallantois. Role of host and preexisting graft blood vessels

DH Ausprunk, DR Knighton and J Folkman

Adult, embryonic, and tumor tissues were grafted to the chorioallantoic membrane of the chick embryo to determine whether blood vessels originally within implants were reused in the establishment of a new blood supply. Grafts were examined daily by in vivo stereomicroscopy and in histologic sections. Colloidal carbon injections into the host vasculature served to confirm the precise onset of graft circulation; Preexisting tumor blood vessels disintegrated by 24 hours after implantation and revascularization occurred at 3 days by penetration of proliferating host vessels into the tumor tissue. Adult tissues did not revascularize, and the original graft vasculature progressively disintegrated during the 9 days of observation, Most embryonic tissues revascularized in 1 or 2 days by reperfusion of the existing graft vasculature. Anastomosis of host and graft blood vessels seemed to result from connections between newly formed vascular sprouts arising from both vasculatures. This study indicates that only tumor grafts acquire their blood supply solely by formation of new blood vessels from the host microvasculature. By contrast revascularization of normal tissues, when it does occur, is predominately the result of perfusion of the preexisting graft blood vessels.

This article has been cited by other articles:

				J. J. Bergh, H.-Y. Lin, L. Lansing, S. N. Mohamed, F. B. Davis, S. Mousa, and P. J. Davis Integrin {alpha}V{beta}3 Contains a Cell Surface Receptor Site for Thyroid Hormone that Is Linked to Activation of Mitogen-Activated Protein Kinase and Induction of Angiogenesis Endocrinology, July 1, 2005; 146(7): 2864 - 2871. [Abstract] [Full Text] [PDF]

				O. D. Liang, T. Korff, J. Eckhardt, J. Rifaat, N. Baal, F. Herr, K. T. Preissner, and M. Zygmunt Oncodevelopmental {alpha}-Fetoprotein Acts as a Selective Proangiogenic Factor on Endothelial Cell from the Fetomaternal Unit J. Clin. Endocrinol. Metab., March 1, 2004; 89(3): 1415 - 1422. [Abstract] [Full Text] [PDF]

				S. A. Gulec and E. A. Woltering A New In Vitro Assay for Human Tumor Angiogenesis: Three-Dimensional Human Tumor Angiogenesis Assay Ann. Surg. Oncol., January 1, 2004; 11(1): 99 - 104. [Abstract] [Full Text] [PDF]

				K. Tahtis, F.-T. Lee, J. M. Wheatley, P. Garin-Chesa, J. E. Park, F. E. Smyth, Y. Obata, E. Stockert, C. M. Hall, L. J. Old, et al. Expression and Targeting of Human Fibroblast Activation Protein in a Human Skin/Severe Combined Immunodeficient Mouse Breast Cancer Xenograft Model Mol. Cancer Ther., August 1, 2003; 2(8): 729 - 737. [Abstract] [Full Text] [PDF]

				A. C. Lockhart, R. D. Braun, D. Yu, J. R. Ross, M. W. Dewhirst, J. S. Humphrey, S. Thompson, K. M. Williams, B. Klitzman, F. Yuan, et al. Reduction of Wound Angiogenesis in Patients Treated with BMS-275291, a Broad Spectrum Matrix Metalloproteinase Inhibitor Clin. Cancer Res., February 1, 2003; 9(2): 586 - 593. [Abstract] [Full Text] [PDF]

				M. Zygmunt, F. Herr, S. Keller-Schoenwetter, K. Kunzi-Rapp, K. Munstedt, C. V. Rao, U. Lang, and K. T. Preissner Characterization of Human Chorionic Gonadotropin as a Novel Angiogenic Factor J. Clin. Endocrinol. Metab., November 1, 2002; 87(11): 5290 - 5296. [Abstract] [Full Text] [PDF]

				M.-S. Lee, E.-J. Moon, S.-W. Lee, M. S. Kim, K.-W. Kim, and Y.-J. Kim Angiogenic Activity of Pyruvic Acid in in Vivo and in Vitro Angiogenesis Models Cancer Res., April 1, 2001; 61(8): 3290 - 3293. [Abstract] [Full Text]

				B. J. F. Wong, A. M. Karamzadeh, M. J. Hammer-Wilson, L.-H. L. Liaw, J. S. Nelson, and T. E. Milner Angioresistance of Thermally Modified Cartilage Grafts in the Chick Chorioallantoic Membrane Model Arch Facial Plast Surg, January 1, 2001; 3(1): 24 - 27. [Abstract] [Full Text] [PDF]

				E. Malik, A. Meyhofer-Malik, Ch. Berg, W. Bohm, K. Kunzi-Rapp, K. Diedrich, and A. Ruck Fluorescence diagnosis of endometriosis on the chorioallantoic membrane using 5-aminolaevulinic acid Hum. Reprod., March 1, 2000; 15(3): 584 - 588. [Abstract] [Full Text] [PDF]

				H. Wu, G. Beuerlein, Y. Nie, H. Smith, B. A. Lee, M. Hensler, W. D. Huse, and J. D. Watkins Stepwise in vitro affinity maturation of Vitaxin, an alpha vbeta 3-specific humanized mAb PNAS, May 26, 1998; 95(11): 6037 - 6042. [Abstract] [Full Text] [PDF]

				K. R. Dover and A. W. Valley Review : Angiogenesis: A new target for antineoplastic therapy Journal of Oncology Pharmacy Practice, January 1, 1996; 2(1): 43 - 60. [Abstract] [PDF]

				P. Brooks, R. Clark, and D. Cheresh Requirement of vascular integrin alpha v beta 3 for angiogenesis Science, April 22, 1994; 264(5158): 569 - 571. [Abstract] [PDF]

				V Muthukkaruppan and R Auerbach Angiogenesis in the mouse cornea Science, September 28, 1979; 205(4413): 1416 - 1418. [Abstract] [PDF]